articleNew England Journal of MedicineNov 14, 2006BRONZE OA

Tolvaptan, a Selective Oral Vasopressin V 2 -Receptor Antagonist, for Hyponatremia

RWRobert W. SchrierPGPeter GroßMGMihai GheorghiadeTBTomás BerlJGJoseph G. Verbalis

Oral Roberts University · University of Colorado Denver · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

BACKGROUND: Hyponatremia (serum sodium concentration,

Citation impact

1,208
total citations
FWCI
48.16
Percentile
100%
References
33
Citations per year

Authors

7

Topics & keywords

Topics
Keywords
  • Tolvaptan
  • Hyponatremia
  • Medicine
  • Vasopressin
  • Antagonist
  • Internal medicine
  • Vasopressin Antagonists
  • Cirrhosis
UN Sustainable Development Goals
  • Clean water and sanitation
No related works found for this paper.

Funding